Fox Run Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$732K Buy
1,892
+782
+70% +$290K 0.12% 316
2026
Q1
$316K Buy
+1,110
New +$365K 0.06% 604
2025
Q1
Sell
-611
Closed -$225K 986
2024
Q4
$225K Sell
611
-574
-48% -$240K 0.04% 727
2024
Q3
$616K Buy
1,185
+327
+38% +$175K 0.14% 273
2024
Q2
$465K Sell
858
-1,524
-64% -$806K 0.09% 434
2024
Q1
$1.24M Buy
+2,382
New +$1.18M 0.27% 76
2023
Q4
Sell
-2,515
Closed -$1.1M 799
2023
Q3
$1.1M Buy
+2,515
New +$1.14M 0.32% 53
2022
Q4
Sell
-1,466
Closed -$666K 694
2022
Q3
$666K Buy
+1,466
New +$701K 0.26% 89
2022
Q1
Sell
-580
Closed -$269K 554
2021
Q4
$269K Buy
+580
New +$244K 0.16% 268
2021
Q2
Sell
-702
Closed -$252K 373
2021
Q1
$252K Buy
+702
New +$226K 0.45% 113
2020
Q3
Sell
-1,534
Closed -$403K 219
2020
Q2
$403K Buy
+1,534
New +$409K 0.53% 39
2019
Q2
Sell
-883
Closed -$253K 476
2019
Q1
$253K Buy
+883
New +$255K 0.14% 325
2018
Q4
Sell
-1,447
Closed -$397K 566
2018
Q3
$397K Sell
1,447
-778
-35% -$202K 0.17% 262
2018
Q2
$530K Buy
2,225
+118
+6% +$27.3K 0.17% 223
2018
Q1
$463K Buy
+2,107
New +$495K 0.11% 336

Other funds holding ELV

Fox Run Management's ELV Position: Q2 2026 in Review

Fox Run Management increased its Elevance Health (ELV) stake by 70% in Q2 2026, buying an estimated $290K and bringing the position to 1,892 shares worth $732K. The position accounts for 0.12% of the portfolio, ranked #316.

Fox Run Management first reported a position in ELV in Q1 2018 and has held it in 15 quarters since. The position peaked at $1.24M in Q1 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fox Run Management held 1,892 shares of Elevance Health worth $732K as of Q2 2026.
  • Fox Run Management bought 782 Elevance Health shares in Q2 2026, an estimated $290K.
  • Elevance Health made up 0.12% of Fox Run Management's portfolio in Q2 2026, its #316 holding.
  • Fox Run Management first reported a position in Elevance Health in Q1 2018 and has held it in 15 quarters since.
  • Fox Run Management's Elevance Health position peaked at $1.24M in Q1 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.